+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Contract Dose Manufacturing"

From
From
Unit Dose Manufacturing Global Market Report 2024 - Product Thumbnail Image

Unit Dose Manufacturing Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
The Pharmaceutical Industry in South Africa 2023 - Product Thumbnail Image

The Pharmaceutical Industry in South Africa 2023

  • Report
  • August 2023
  • 405 Pages
  • South Africa
From
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Contract dose manufacturing is a service provided by pharmaceutical companies to produce drugs and other pharmaceutical products. It involves the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for customers. Contract dose manufacturing is a cost-effective way for pharmaceutical companies to outsource the production of their products. It also allows them to focus on their core competencies, such as research and development, while leaving the manufacturing to a third-party. Contract dose manufacturing is a highly regulated process, with strict quality control measures in place to ensure the safety and efficacy of the products. Some of the companies in the contract dose manufacturing market include Boehringer Ingelheim, Catalent, Lonza, Patheon, Recipharm, and Vetter. Show Less Read more